MedTrace Logo

Integrated Cognitive Behavioral Therapy (ICBT) for Posttraumatic Stress Disorder (PTSD) and Substance Use Disorders

NCT01457404 · Status: COMPLETED · Phase: PHASE3 · Type: INTERVENTIONAL · Enrollment: 56

Last updated 2015-10-26

No results posted yet for this study

Summary

The purpose of this study is to assess the safety and practicality, feasibility and efficacy of ICBT for co-occurring PTSD and substance use disorders within the OEF/OIF/OND Veterans population, as delivered by routine clinicians at the Veterans Affairs.

Conditions

  • Stress Disorder, Post-Traumatic
  • Substance-Related Disorders

Interventions

BEHAVIORAL

Integrated Cognitive Behavioral Therapy

Individual or group ICBT, approx. 12 sessions, one session per week

BEHAVIORAL

Treatment-as-usual

Individual or group therapy as usual within the SATP or PTSD clinics at the PVAMC

Sponsors & Collaborators

  • Brown University

    collaborator OTHER

  • Providence VA Medical Center

    collaborator FED

  • National Institute on Drug Abuse (NIDA)

    collaborator NIH

  • Dartmouth-Hitchcock Medical Center

    lead OTHER

Principal Investigators

  • Mark P. McGovern, Ph.D. · Dartmouth-Hitchcock Medical Center

Study Design

Allocation
RANDOMIZED
Purpose
TREATMENT
Masking
NONE
Model
PARALLEL

Eligibility

Min Age
18 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2011-02-28
Primary Completion
2015-06-30
Completion
2015-06-30

Countries

  • United States

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT01457404 on ClinicalTrials.gov